Wow, look at PARD.
Biotechs are unforgiving.
SVA sells off.
You need combat gear to na vigate this industry, lol.

SVA reported this morning and getting a little pop.

OK, off to work!

Sinovac Biotech receives purchase order from Shanghai government to supply hepatitis A
vaccine HealiveFont size: A | A | A1:53 AM ET 11/16/09 | Briefing.com
RELATED QUOTES


November 13, 2009
Symbol Last % Chg
SVA 9.38 0.00%
Real time quote.

Co announces that it was selected by the Shanghai Government to supply its inactivated
hepatitis A vaccine, Healive, to the public market of Shanghai. Out of the five vaccine
manufacturers that participated in the bidding process, the Shanghai Government awarded
Sinovac the entire hepatitis A vaccine purchase order, valued at RMB 20.6 million, or
approx $3.0 million. Pursuant to the agreement, Sinovac will supply Healive over the next
twelve months.

Last edited on: 11-16-2009 07:29 am

Co announces it has received a Complete Response Letter from the FDA relating to the
Company's Biologics License Application requesting the approval of raxibacumab for use in
the treatment of inhalational anthrax. The FDA issues Complete Response Letters to request
additional information needed to complete the review of a BLA. "We have responded to all
of FDA's previous questions. We plan to address the current questions as well, In certain
respects, the Complete Response Letter appears to be inconsistent with the FDA's published
final rule governing the development of new drugs when human efficacy studies are not
ethical or feasible... It is unfortunate that it was not possible to resolve these
questions before the PDUFA date passed. However, HGS has delivered 20,000 doses of
raxibacumab to the U.S. Strategic National Stockpile under our contract with BARDA, so it
is currently available in the Stockpile for use in the event of an emergency while we
complete our discussions with the FDA.

Last edited on: 11-16-2009 07:28 am

Human Genome receives complete response letter from FDA for Raxibacumab biologics license
applicationFont size: A | A | A7:03 AM ET 11/16/09 | Briefing.com

Down almost 5 percent in pre-pre. What the heck is this about?

Last edited on: 11-16-2009 07:13 am

The story I read with regards to SVA - prior to Swine outbreak - SVA's revenue from H1N1
vaccine was only 10 percent. Story said SVA has been exact about outlining sales but has
not yet released expected revenue increase from it. From the "tone" of this story, I don't
think these two deaths are indicative of a potentially defective vaccine.

I've been reading a lot about SVA but, could it have been this news story that sent the
stock down to 8.63 and then back up to 9.20 range on Friday? Ibankcoin.com says SVA
reports Monday but E Trade's date is Nov. 30.
When I was in Manhattan Labor Day weekend I met an executive from Pfizer who said the
vaccine industry was where it's at and that PFE would do well once it closed its
acquisition of Wyeth. His opinion. I also notice my ETF VHT has ralliued recently after
lagging in performance.

BEIJING — Two people in China who received swine flu vaccinations died in the past week
but at least one death appears unrelated to the vaccine and the other was being
investigated.

The country's health ministry reported the deaths late Friday on its Web site — the
first time China has announced deaths with potential links to the Chinese-made swine flu
vaccine.

An autopsy showed one victim suffered a heart attack and, "experts have basically ruled
out the possibility that the patient's sudden death was the result of immediate allergic
reactions to the flu vaccines," the ministry statement said.

Experts were waiting for more lab results, it added.

An autopsy on the second person was scheduled for late Friday, but no results had been
reported Saturday morning.

The statement gave no details on the two people, and phone calls to China's health
ministry went unanswered Saturday.

The Hunan provincial health department in southern China posted a statement on its Web
site Friday saying a teacher died Monday while playing basketball, eight hours after being
vaccinated.

A spokeswoman for the World Health Organization office in China said the second death was
a man from Tianjin, southeast of Beijing.

"Our assessment of the safety of the Chinese vaccine hasn't changed," said spokeswoman
Vivian Tan. "The deaths are unfortunate, but we need to get to the bottom of it."

The health ministry has said more than 13 million Chinese have received the swine flu
vaccine.

"So far from the sheer numbers vaccinated, there's a very small number of mild and ever
smaller number of serious reactions. We still believe it is generally safe and effective,"
Tan said.

The health ministry statement said 1,235 people had been suspected of having abnormal
reactions to the vaccine as of Wednesday. Reactions included fever and swelling.

Fifteen people had relatively serious responses such as anaphylactic shock, a severe
allergic reaction that can be deadly.

The health ministry statement said the vaccines are generally safe and vaccinations will
continue.

As of Friday, China reported about 66,000 cases of swine flu, including 43 deaths.

I see that IBB seems to be on its way up
(www.finviz.com).

TNDM = *pop*

Hope it lasts....

dndn submits provenge (?) for fda approval.